Seeking Alpha on MSN13h
Henry Schein extends gain on report of activist stake, push for board changes
Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...
Seeking Alpha on MSN13h
Henry Schein gains amid activist speculation after 13F filing, conference appearance
Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products distributor may have attracted an activist investor. The company also presented ...
Analyst Ratings For Henry Schein
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...
Business Insider19h
Ananym urges Henry Schein to cut spending, sell unit, Reuters reports
Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...
Henry Schein’s Sell Rating: Internal Sales Weakness and Valuation Concerns Amidst Cybersecurity and Market Challenges
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...
Nasdaq12d
Analyst Ratings For Henry Schein
Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below summarizes their recent ratings, showcasing the ...